Peramivir is a novel cyclopentane neuraminidase inhibitor of influenza virus. It was
approved by the Food and Drug Administration in December 2014 for treatment of acute …

In the last few years, several new direct-acting influenza antivirals have been licensed, and
others have advanced in clinical development. The increasing diversity of antiviral classes …

A target-free approach was applied to discover anti-influenza viral compounds, where
influenza infected Madin–Darby canine kidney cells were treated 7500 different small …

Background Guidelines emphasize prompt antiviral treatment in severe influenza patients.
Although nearly a 50% of severe influenza present with pneumonia, the effect of early (≤ 2 …

INTRODUCTION: Patients with acute respiratory failure due to influenza require ventilatory
support. However, mechanical ventilation itself can exacerbate lung damage and increase …

Sorgen bereiten der WHO gegenwärtig vor allem zwei neue Viren: Influenza A H7N9 und
MERS-CoV. Das Vogelgrippevirus H7N9 ist einer von mehreren Influenzavirusstämmen, die …

On 15th December 2014, a meeting was held at the Faculty of Public Health (FPH) to gain
views and where possible consensus on the prophylactic use among the general population …